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Purpose: To determine if focused ultrasonography (US) combined
with a diagnostic microbubble-based US contrast agent
can be used to modulate glomerular ultrafiltration and size
selectivity.
Materials and
Methods:
The experiments were approved by the animal care com-
mittee. The left kidney of 17 healthy rabbits was sonicated
by using a 260-kHz focused US transducer in the presence
of a microbubble-based US contrast agent. The right kid-
ney served as the control. Three acoustic power levels
were applied: 0.4 W (six rabbits), 0.9 W (six rabbits), and
1.7 W (five rabbits). Three rabbits were not treated with
focused US and served as control animals. The authors
evaluated changes in glomerular size selectivity by measur-
ing the clearance rates of 3000- and 70 000-Da fluores-
cence-neutral dextrans. The creatinine clearance was cal-
culated for estimation of the glomerular filtration rate. The
urinary protein-creatinine ratio was monitored during the
experiments. The authors assessed tubular function by
evaluating the fractional sodium excretion, tubular reab-
sorption of phosphate, and -glutamyltransferase–creati-
nine ratio. Whole-kidney histologic analysis was per-
formed. For each measurement, the values obtained be-
fore and after sonication were compared by using the
paired t test.
Results: Significant (P  .05) increases in the relative (ratio of
treated kidney value/nontreated kidney value) clearance
of small- and large-molecule agents and the urine flow
rates that resulted from the focused US treatments were
observed. Overall, 1.23-, 1.23-, 1.61-, and 1.47-fold en-
hancement of creatinine clearance, 3000-Da dextran
clearance, 70 000-Da dextran clearance, and urine flow
rate, respectively, were observed. Focal tubular hemor-
rhage and transient functional tubular alterations were
observed at only the highest (1.7-W) acoustic power level
tested.
Conclusion: Glomerular ultrafiltration and size selectivity can be tem-
porarily modified with simultaneous application of US and
microbubbles. This method could offer new opportunities
for treatment of renal disease.
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Various ultrasonographically (US)generated acoustic mechanical ef-fects can induce transient changes
in cell permeability and function (1–3).
These effects, often termed sonopora-
tions, can be enhanced with a micro-
bubble-based US contrast agent (4) and
have been tested as possible methods of
enhancing the delivery of drugs and
genes.
US combined with microbubbles can
also be used to enhance vascular perme-
ability. Low-intensity focused US (hereaf-
ter, focused US) exposures (ie, sonica-
tions) combined with the administration
of gas microbubble–based diagnostic US
contrast agents have been shown to tem-
porarily disrupt the blood-brain barrier
(5–11). Although the exact mechanism
underlying this disruption is unknown,
it appears that the sonications in-
crease both passive and active trans-
port mechanisms (7,12) and induce
physiologic changes—namely, tempo-
rary vasospasms (13).
The glomerulus is another vascular
structure that acts as a barrier between
the blood and the formative urine. Glo-
merular ultrafiltration is a hemodynami-
cally regulated event that is modulated
through the glomerular barrier (14). This
barrier has physical properties that can
be dynamically changed. These proper-
ties include the thickness and charge of
the glomerular basement membrane and
the spread of the epithelial layer of the slit
diaphragm to increase or decrease the
glomerular ultrafiltration coefficient, as
needed, to reach filtration pressure equi-
librium (15–18). Our purpose in this
study was to determine if focused US
combined with a diagnostic microbubble-
based US contrast agent can be used to
modulate glomerular ultrafiltration and
size selectivity.
Materials and Methods
All procedures performed in the animal
experiments were approved by the insti-
tutional animal care committee of Har-
vard Medical Area. We treated the ex-
posed left kidney of 17 healthy rabbits
with focused US and amicrobubble-based
US contrast agent (10 L/kg perflutren
lipid microspheres, Definity; Bristol-
Myers Squibb Medical Imaging, North
Billerica, Mass). The right kidney served
as the control. Three acoustic power lev-
els were applied: 0.4 W (six rabbits), 0.9
W (six rabbits), and 1.7 W (five rabbits).
Three rabbits were not treated with fo-
cused US and served as control animals,
and one of these rabbits was injected with
the US contrast agent. Figures 1 and 2
show the experimental setup and the ex-
perimental timeline, respectively.
Animal Preparation
Twenty male New Zealand white rabbits
weighing 3000–3500 g were anesthetized
with a mixture of xylazine (12 mg/kg/hr)
and ketamine (48 mg/kg/hr). Saline solu-
tion infusion (1mL/min) was started after
anesthesia was induced. The left kidney
was surgically exposed for easy targeting
by the acoustic beam. Left-kidney urine
was collected from the bladder with use
of a Foley catheter placed in the urethra.
The ureter of the right kidney was cut,
and a ureter catheter (Kendall Tyco
Healthcare; Mansfield, Mass) was in-
serted for collection of right-kidney urine.
Blood pressure was continuously moni-
tored during the procedure by using a
polygraph (model 7D; Grass Instruments,
Quincy, Mass) via a cannula placed in the
carotid artery. A catheter for intravenous
injection was placed in the left ear vein.
Experimental Setup
The focused US transducer was housed in
a manually operated mechanical position-
ing system and submerged in a tank of
degassed deionized water (Fig 1). The an-
imal lay on its side on a plastic tray that
had a 3  5-cm rectangular hole cut in it
and was mounted on the top of the tank.
A thin plastic sheet was loosely attached
to the top of the tray and pushed through
the rectangular hole to form a bag that
was filled with degassed water, the tem-
perature of which was monitored and
maintained at about 37°C with use of a
heating coil. The exposed left kidney hung
in the water bag. The bottom of the water
bag rested on a taut, acoustically trans-
parent plastic membrane that was
mounted below it.
US Procedure
The acoustic fields were generated with
an air-backed, spherically curved trans-
ducer (frequency, 260 kHz; curvature di-
ameter, 10 cm; curvature radius, 8 cm)
that was manufactured in-house. The
transducer was powered by a function
generator (model 276; Fluke, Everett,
Wash) and a radiofrequency amplifier
(model 240L; E & I, Rochester, NY).
Electrical power was measured with a
power meter (model E419B; Agilent,
Santa Clara, Calif) and a dual directional
coupler (model C5948-10; Werlatone,
Brewster, NY). Methods used to charac-
terize the transducer are described else-
where (19). The half-intensity beam di-
ameter and the length of the focal spot
were 8 and 40 mm, respectively, as mea-
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Advances in Knowledge
 Focused US with simultaneous
administration of a US micro-
bubble-based contrast agent can
noninvasively induce temporary
glomerular filtration rate en-
hancement in healthy rabbits and
thus is potentially applicable to
injured kidney function.
 Focused US treatment in the pres-
ence of microbubbles enhances
the clearance of large-molecule
agents—herein 70 000-Da dex-
tran—that normally are not
cleared from the kidney.
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sured in beam plots of the pressure am-
plitude squared. With such a long focal
length, it was assumed that any US effects
would occur through the entire thickness
of the kidney within the focal spot. The
frequency was selected on the basis of
previous research of US-induced blood-
brain barrier disruption, which revealed
that lower frequencies result in less hem-
orrhage (20). The large size of the focal
spot at this frequency also enabled us to
target a fairly large portion of the kidney
within a reasonable amount of time with
use of our manual positioning system.
Each sonication consisted of 30 10-
msec pulses at a repetition frequency of 1
Hz. The targets were located approxi-
mately 1 cm deep into the kidney in a
single plane. Fifteen targets were soni-
cated at 1-cm intervals to encompass the
extent of the 3  5-cm rectangular hole
through which the kidney was hanging
(Fig 1). As can be seen in the inset in
Figure 1, some of the sonications were
not in the kidney and were in the water
only. We estimate that we targeted ap-
proximately 50% of the kidney volume.
This approximation was based on mea-
surements made on magnetic resonance
images of a rabbit kidney in an unrelated
(nonpublished) study and assumptions
that the diameter of the affected area at
each sonication was equal to the half-
intensity beam diameter (8 mm) and the
entire thickness of the kidney was af-
fected along the direction of the focused
ultrasound beam. Three acoustic power
levels were tested: 0.4, 0.9, and 1.7 W.
These exposure levels corresponded to
negative pressure amplitudes (spatial
peak, temporal peak estimates) of 0.30,
0.41, and 0.58 MPa in the focal plane,
respectively, with the assumption of an
acoustic attenuation of 6.5 Nepers/m/
MHz (with use of average of values in a
previous study [21]).
A bolus of US contrast agent (per-
flutren lipid microspheres) was injected
intravenously at a dose of 10 L/kg at the
start of each of the 15 sonications andwas
followed by a 2-mL saline solution injec-
tion to flush the agent from the catheter.
A delay between sonications of approxi-
mately 2 minutes allowed most of the
bubbles to clear from the circulation. A
hydrophone was used tomonitor acoustic
emission during sonication (Appendix E1,
http://radiology.rsna.org/cgi/content
/full/2532082100/DC1).
Evaluation of Kidney Function
To evaluate the size selectivity of the glo-
merular barrier, we intravenously in-
jected 3000- and 70 000-Da fluorescent
dextrans (Invitrogen, Eugene, Ore), con-
jugated with rhodamine green (maximal
absorption, 502 nm; maximal emission,
527 nm) and rhodamine B (maximal ab-
sorption, 570 nm; maximal emission, 590
nm), into the ear vein at concentrations of
1 and 2mg/mL, respectively (injected vol-
umes, 0.125 and 0.187 mL/kg, respec-
tively), after the first blood and urine
measurements and again immediately af-
ter the sonications. To estimate the glo-
merular filtration rate (GFR), we calcu-
lated the creatinine clearance rate. The
protein-creatinine ratio was computed
with every measurement.
The fluorescence intensities of the
3000- and 70 000-Da dextrans were mea-
sured by using a fluorescent microplate
reader (Gemini Fluorescent Microplate
Reader; Molecular Devices, MDS Analyt-
Figure 1
Figure 1: Diagram of experimental setup. The left kidney was exteriorized and targeted with focused US.
Urine produced by this kidney was sampled from the bladder with use of a Foley catheter. The right kidney was
exposed, and a ureter catheter was used to acquire urine from this kidney. Inset at bottom right shows the pat-
tern of 15 sonication targets in the focal plane, encompassing the reservoir in which the left kidney was hang-
ing.ADC anolog-to-digital converter, i.v. intravenous,PC personal computer.
Figure 2
Figure 2: Timeline used in each experiment. Blood (B) and urine (U) samples were acquired at 15-minute intervals. The animal was placed on the apparatus 30 min-
utes before any measurements began. This interval allowed the animal to stabilize on the stage. After this time, the urine from each kidney was collected separately in test
tubes. To measure the urine flow rate, the test tubes were removed every 15 minutes and replaced with empty tubes. At the midpoint of each urine collection, a 0.7-mL
blood sample was taken from the carotid artery. A total of 13 measurements were obtained in each animal.
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ical Technology, Toronto, Ontario, Can-
ada). Known dilutions of the dextrans in
plasma and urine were produced, and the
fluorescence intensities were measured
to estimate the concentrations and clear-
ances in the experiments.
Wemeasured the creatinine, sodium,
phosphate, and urinary protein concen-
trations in plasma and urine and the
-glutamyltransferase activity by using
routine laboratory methods and a chemi-
cal analyzer (Hitachi 912; Roche Diagnos-
tics, Mannheim, Germany). We esti-
mated the tubular function by evaluating
the fractional excretion of sodium, which
is a measure of the percentage of sodium
excreted in the urine versus the sodium
reabsorbed by the kidney; the tubular re-
absorption of phosphate; and the -glu-
tamyltransferase–creatinine ratio. Calcu-
lationmethods are described in Appendix
E2 (http://radiology.rsna.org/cgi/content
/full/2532082100/DC1).
Histologic Examination
The animals were sacrificed 1.5 hours af-
ter treatment, and their kidneys were
harvested, fixed, embedded, and serially
sliced. This survival time was chosen to
determine the duration of the induced
functional alterations. All of the treated
and control kidneys were evaluated for
histologic abnormalities with use of he-
matoxylin-eosin and periodic acid-Schiff
staining every 50th and 51st slice, respec-
tively. One author (M.K.), a renal pathol-
ogist, performed the histologic evalua-
tions without knowledge of whether the
sample was a control or treated speci-
men.
Data Analyses
In each animal, the relative clearance ra-
tio (treated left kidney value/untreated
right kidney value) for clearance of the
fluorescent dextrans and creatinine and
the urine flow rate were determined as
functions of time. To test the effects of
focused US treatment on these measure-
ments, we compared the mean ratio be-
fore the treatment (mean of second to
fifth measurements) with the mean ratios
during and immediately after the treat-
ment (mean of seventh to ninth measure-
ments) and themean ratios at a later time
after the treatment (mean of 10th to 13th
measurements) by using the paired t test.
Measurement 6 was not used because in
some experiments, this measurement
took longer than the other measure-
ments.
Statistical Analyses
Power analysis was applied for all groups
and all parameters to justify the small
sample size. In every case, the statistical
power was found to be greater than 80%.
The Kolmogorov-Smirnov test was used
to determine if the measurements were
normally distributed. We found a normal
distribution of all examined parameters
(clearance of creatinine and the two dex-
trans, urine flow rate) in each group be-
fore, during, and after the focused US
treatment. To determine whether the ob-
served enhancements in the clearances
were significant, we performed paired t
tests. Differences were considered signif-
icant at P  .05.
Two-way (time and power level) anal-
ysis of variance of the interaction be-
tween time and treatment was per-
formed, with the animals nested within
power level to justify the combination of
the different power level groups for sta-
tistical analysis. The interactions were
not significant and thus led us to conclude
that we could not detect a power-depen-
dent effect in these results. To determine
the significance of the US-induced tempo-
rary effects, the mean of measurements
10–13 was compared with the baseline
value (mean of pretreatment measure-
ments 2–5) and the paired t test was ap-
plied to determine the significance of the
difference. Statistical analysis software
(SPSS; SPSS, Chicago, Ill) was used to
perform the statistical analyses.
Results
Alterations in Glomerular Ultrafiltration
and Permselectivity
During and immediately after focused
US (measurements 7–9), 1.54-, 1.56-,
and 1.70-fold elevations in the relative
(treated compared with nontreated
kidney) clearance of the 70 000-Da
dextran were observed for the 0.4-,
0.9-, and 1.7-W treatment groups, re-
spectively. These elevations were ac-
companied by 1.41-, 1.43-, and 1.63-
fold increases in the urine flow rate.
The ratios for relative 70 000-Da dex-
tran clearance (P  .046, P  .045,
and P  .048 for 0.4-, 0.9-, and 1.7-W
treatment groups, respectively) and
relative urine flow rate (P  .045, P 
.020, and P  .048 for 0.4-, 0.9-, and
1.7-W treatment groups, respectively)
were significantly larger than the pre-
treatment values (Fig 3). After fo-
cused US treatment (measurements
10–13), these ratios were not signifi-
cantly different from the pretreatment
values, suggesting that the effect was
temporary. In five animals, no changes
in relative creatinine clearance or rel-
ative 3000-Da dextran clearance were
observed during or immediately after
focused US. In another animal, com-
paratively large changes were ob-
served: 3.00- and 2.48-fold increases
in creatinine and 3000-Da dextran
clearance, respectively. These six an-
imals were considered outliers.
Enhancement was observed in the 11
remaining animals. Creatinine clearance
ratios increased 1.27-, 1.28-, 1.27-fold,
and 3000-Da dextran clearance ratios in-
creased 1.35-, 1.35-, and 1.36-fold with
sonications of 0.4, 0.9, and 0.7 W, re-
spectively. The overall enhancement for
both creatinine clearance and 3000-Da
dextran clearance was 1.23 fold. Al-
though enhancement ratios for the indi-
vidual power levels were not significantly
different from pretreatment values, when
the power levels were combined, the
overall enhancement was significant (P
.04 for relative creatinine clearance, P 
.027 for relative 3000-Da dextran clear-
ance) (Fig 4). This enhancement was also
significant when the outliers were in-
cluded. At measurements 10–13 after
treatment, the clearance ratios were not
significantly different from the pretreat-
ment values. No significant changes were
observed in the control animals.
Focused US treatment at 0.4 W did
not result in an elevated protein-to-
creatinine ratio. At 0.9 W, this ratio was
elevated but still within the normal range
(ie, within the rangemeasured in the con-
trol animals). At the highest power level
(1.7 W), this ratio exceeded the normal
range (Fig 5). The elevated protein-to-
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creatinine ratio returned to the normal
range 45 minutes after the treatment
ended. Although 0.4-W sonication did not
elevate the fractional sodium excretion,
the two higher-power-level treatments
temporarily increased it: 1.32-fold in
three of six cases at 0.9W and in three of
five cases at 1.7 W. Fractional sodium
excretion returned to baseline 30minutes
after the treatment ended. The tubular
reabsorption of phosphate and the -glu-
tamyltransferase–creatinine ratio were
not altered substantially at any power
level. Blood pressure was stable in all
cases.
Histologic Analysis
No anatomic damage at the two lower-
power (0.4 and 0.9 W) levels was ob-
served in the hematoxylin-eosin–stained
sections (Fig 6). Minor tubular hemor-
rhage appeared after sonication at 1.7W.
No interstitial hemorrhage was seen at
any power level. Periodic acid-Schiff
staining revealed intact proximal tubular
brush borders and normal tubular struc-
ture at every power level (Fig 6).
Acoustic Emission
Bubble activity was observed during
many sonications. This activity appeared
as a large increase in spectral energy at
and around the resonant frequency of the
passive cavitation detector (Fig 7). Emis-
sion at the harmonics of the US fre-
quency, as well as subharmonic and ultra-
harmonic emissions at one-half and
three-halves the US frequency, respec-
tively, was observed. Such activity was
not observed when the sonication oc-
curred in water only or when the sonica-
tions were applied before the treatment
without the microbubble contrast agent.
Discussion
We tested the hypothesis that low-
power US bursts combined with a mi-
crobubble contrast agent can affect the
renal barrier function. With use of son-
ication parameters developed to tempo-
rarily disrupt the blood-brain barrier,
we observed an approximately 60% in-
crease in the relative clearance of the
70 000-Da dextran during the focused
US treatment and, on the basis of the
relative clearance of two independent
small-molecule agents that are freely fil-
tered in the glomerulus (creatinine and
3000-Da dextran), a 30% elevation in glo-
Figure 3
Figure 3: (a) Relative (left treated kidney/right control kidney) clearance of the 70 000-Da dextran and (b) relative urine flow rate before and after focused US treatment
with microbubbles. The sonications produced significant (P .05 [],P .01 []) enhancement (P .046,P .045, andP .048 for relative 70 000-Da dextran
clearance;P .045,P .020, andP .048 for relative urine flow rate) that was not observed in the control animals. Mean values standard deviations are shown.
Figure 4
Figure 4: (a) Relative (left treated kidney/right nontreated kidney) creatinine clearance and (b) relative 3000-Da dextran clearance before and after focused US treat-
ment with microbubbles. The sonicated regions had significant (P .05 []) enhancement when all the treatment groups were combined (P .04 for relative creatinine
clearance,P .027 for relative 3000-Da dextran clearance); however, enhancement in the individual groups was not significant. Mean values standard deviations are
shown.
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merular ultrafiltration. These increases in
relative clearance rates started at the be-
ginning of the focused US treatment and
ended within 30 minutes of treatment
completion.
The mechanisms by which US com-
bined with the microbubble contrast
agent causes glomerular ultrafiltration en-
hancement are not known. Several bio-
logical effects could result from the inter-
action between the ultrasound beam and
the microbubbles and the subsequent
acoustic-mechanical effects. The shelled
bubbles can fragment, and the resulting
free bubbles may oscillate within the
acoustic field and grow by means of rec-
tified diffusion. At sufficient acoustic pres-
sure, they can collapse during the positive
pressure cycle—a phenomenon known as
inertial cavitation—and produce shock
waves, high-velocity microjets, free radi-
cals, and high local temperatures (22).
Other potential effects include acoustic
streaming of the fluid surrounding the
bubbles, which could result in large shear
stresses at the vessel walls, and a direct
impulse on the vessels owing to the oscil-
lation of the bubble or radiation force.
The bubble oscillation may also produce
sharp temporary pressure changes within
the vessel (22). On the basis of prior
brain research in which US bursts com-
bined with similar microbubbles were
used (5), we do not believe that bulk tis-
sue heating caused the observed effects.
In that work, in which heating from the
exposures that disrupted the blood-brain
barrier was not observed, the investiga-
tors used US parameters that were ex-
pected to produce heating greater than
that induced by the low-frequency expo-
sures used in the current study.
Figure 5
Figure 5: Relative protein-creatinine ratio as a function of time. Focused US treatment was started at mea-
surement 7 and ended at measurement 8 (total of 13 measurements). The maximal increase in relative protein-
creatinine ratio after the start of treatment was compared with the pretreatment value (measurement 6). Ob-
served changes were significant for the 0.9-W (P .002) and 1.7-W (P .004) treatment groups. Means
standard deviations are shown.
Figure 6
Figure 6: Microphotographs of hematoxylin-eosin–stained (top row) and periodic acid-Schiff–stained (bottom row) sections show histologic findings after focused
US treatment at different acoustic power levels. At the highest power level, small tubular damage (arrow) is evident in some hematoxylin-eosin–stained sections. The
periodic acid-Schiff–stained sections have a normal appearance. (Original magnification,60.)
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The most harmful event that can be
induced is inertial cavitation, which may
cause hemorrhage and tissue damage
(23). Neither of these events was ob-
served at sonication power levels below
the highest level tested. The fact that in-
terstitial hemorrhage was not observed at
all perhaps suggests that inertial cavita-
tion was not dominant. However, some
enhanced acoustic emission at the reso-
nant frequency of our hydrophone, con-
sistent with wideband emission—an indi-
cator of inertial cavitation—was ob-
served. This interpretation may have
been confounded by ultraharmonic emis-
sion at five-halves the US frequency,
which was the same as the resonant fre-
quency of our detector. Such emission
was probably present since ultrahar-
monic emission at three-halves the US
frequency was also observed. Future re-
search with a different cavitation detector
will be necessary to determine whether
the observed emission was wideband
emission, which is indicative of inertial
cavitation, or ultraharmonic emission,
which is indicative of stable cavitation.
Previous brain research suggests that in-
ertial cavitation is not necessary to pro-
duce blood-brain barrier disruption (24–
26), so if the same mechanisms are in-
volved in GFR enhancement, cavitation
may not be necessary.
Regardless of the mechanism, the ca-
pability of the sonicated kidneys to clear
the 70 000-Da dextran and the rapid on-
set of this clearance suggest that the soni-
cations changed the glomerular mem-
brane properties. Previous study investi-
gators who examined the permselectivity
of the glomerularmembrane and the siev-
ing of different-size dextrans found that
the filtration of the 70 000-Da dextran to
the urinary space was extremely limited
under normal circumstances (27,28).
It is also possible that the sonications
triggered a physiologic response from the
glomerular barrier that included a tempo-
rary increase in glomerular filtration. This
effect might be related to vasoconstrictor
stimulation of the efferent arteriole
and/or to vasodilatation of the afferent
arterioles.
Results of relatively recent studies of
healthy animals suggest that the glomer-
ular ultrafiltration coefficient can dynam-
ically change as a function of time to en-
sure filtration pressure equilibrium and
glomerular ultrafiltration stability (15,29).
It was also shown in vitro that the epithe-
lial layer of the glomerular basement
membrane has a contractile phenotype in
response to physiologic stimuli such as
mechanical stress. This observation
in vitro canmirror a capability in vivo that
may influence glomerular basement
membrane permeability and glomerular
ultrafiltration (26).
Although increases in the kidney’s fil-
tration, urine flow, and clearance of a
large-molecule agent were significant and
not observed in the control animals, the
results were highly variable. This variabil-
ity might simply reflect the targeting un-
certainty in these experiments, which
were not imaging guided, or interindi-
vidual variability. Depending on the posi-
tion of the kidney with respect to our grid
of sonication locations, different percent-
ages of the kidney volume could have
been targeted in different animals. Also, it
may be difficult to achieve substantial in-
creases in these effects in healthy kid-
neys, and it is possible that the treated
kidneys that showed only minor enhance-
ment had filtration pressures close to
their equilibrium value and thus could not
manifest further increases. This difficulty
could explain the “all or nothing” re-
sponses that seemed to occur. The vari-
ability in our results, along with the small
sample sizes of the treatment groups, also
may explain why the filtration enhance-
ment did not appear to have a clear de-
pendence on the acoustic power.
Proteinuria did appear to be influ-
enced by the acoustic power and was not
present at the lowest level tested. Sonica-
tion at only the highest power level re-
sulted in proteinuria involving a protein-
creatinine ratio in the abnormal range. At
45 minutes after treatment, however,
urine protein levels returned to the nor-
mal range. This finding may indicate that
excessive exposure levels are associated
with a risk of tubular injury.
The fact that the fractional sodium
excretion changes were transient and oc-
curred at the highest acoustic power level
only, without accompanying changes in
tubular reabsorption of phosphate or uri-
nary -glutamyltransferase–creatinine
excretion, suggests that we induced a
functional change rather than persisting
structural damage. Overall, the increased
creatinine clearance coupled with mini-
mal, transient functional tubular changes
suggests that the sonications induced en-
hancement of the GFR. However, future
research should be conducted to confirm
that the sonications do not cause podo-
cyte detachment from the basement
membrane of the glomerulus or endothe-
lial cell damage that is not visible at light
Figure 7
Figure 7: Measurement of acoustic emission during sonication. Spectra were acquired during pulses
delivered at two locations: one site without evident bubble activity (in water) and one with wideband emission.
EXPERIMENTALSTUDIES:US-induced Changes in Renal Ultrafiltration Fischer et al
Radiology: Volume 253: Number 3—December 2009 ▪ radiology.rsna.org 703
microscopy. Such temporary damage
could explain the observed clearance of
the large-molecule dextran.
Despite these promising findings, this
feasibility study had several limitations.
As mentioned earlier, the sonications
were performed without imaging guid-
ance, which could have ensured precise
targeting of the ultrasound beam on the
renal cortex. Thus, the lack of imaging
guidance may have caused the variability
in results that we observed. Also, we
needed to exteriorize the kidney because
imaging guidance was not used, and this
may have influenced the results. Further-
more, the sonication parameters were
not optimized, and further enhancements
in the GFR may be possible. Studies
should be performed to verify that the
microbubbles are needed to produce the
effect. Survival studies should also be per-
formed to ensure that focused US treat-
ment does not cause delayed effects. Fi-
nally, future research is necessary to de-
termine whether the effects that we
observed are possible in injured or dis-
eased kidneys.
The glomerular membrane has a fun-
damental role in filtration impairment
(27–34). A decrease in glomerular ultra-
filtration is thought to originate from de-
creased hydraulic permeability of the cap-
illary wall (ie, a substantial decrease in
the glomerular ultrafiltration coefficient),
a decreased surface area within the glo-
merulus, a decreased number of function-
ing glomeruli, or some combination of
these factors (35,36). These changes may
have a profound effect on the changes
that can be induced with US.
In conclusion, these study results
show that US bursts combined with mi-
crobubbles can temporarily enhance glo-
merular ultrafiltration and temporarily
enable the passage of large-molecule
agents that are normally not filtered by
the kidney. Further improvements are
possible with optimized US parameters
and appropriate imaging guidance.
Practical applications: A treatment
strategy that has not been tested yet is to
use a mechanical stimulus highly targeted
at the glomeruli to increase the glomeru-
lar ultrafiltration by either directly modi-
fying the membranes involved in ultrafil-
tration or otherwise triggering a vasoac-
tive response. Such a stimulus would be a
powerful tool that leads to opportunities
for novel renal therapies and a new
method of studying kidney function and
disease. The potential applications of this
treatment would be targeted at patients
with chronic kidney function impairment
and/or patients without renal disease
who could benefit from a GFR increase.
For example, patients with severe heart
failure who are resistant to conventional
kidney therapies have high 1-year mortal-
ity (37). Noninvasively increasing the
GFR in these patients would induce a
gradual removal of excess water and salt
without compromising blood pressure
and could help reverse sympathetic and
rennin-angiotensin overactivity. Use of
this method might also generate a tempo-
rary timewindow inwhich to increase the
filtration of even large-molecule sub-
stances that are normally not cleared
from the kidney—for example, toxins
such as Shiga toxin that are produced
during Escherichia coli O157:H7 infec-
tion. Presumably, focused US treatment
could also enhance the efficiency of the
detoxification of smaller-molecule agents,
such as lithium, by inducing a temporary
GFR increase.
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